共 180 条
[1]
Piechocki M(2022)Trends in Incidence and Mortality of Gynecological and Breast Cancers in Poland (1980–2018) Clin Epidemiol 24 95-114
[2]
Koziołek W(2019)Ovarian cancer: Current status and strategies for improving therapeutic outcomes Cancer Med 8 7018-7031
[3]
Sroka D(2014)“Platinum resistant” ovarian cancer: What is it, who to treat and how to measure benefit? Gynecol Oncol 133 624-631
[4]
Matrejek A(2020)CA125 and Ovarian Cancer: A Comprehensive Review Cancers (Basel) 12 3730-1524
[5]
Miziołek P(2014)Prediction of tumour response induced by chemotherapy using modelling of CA-125 kinetics in recurrent ovarian cancer patients Br J Cancer 110 1517-1403
[6]
Saiuk N(2009)CA-125 change following chemotherapy in prediction of treatment outcome among advanced mucinous and clear cell epithelial ovarian cancers: a gynecologic oncology group study Cancer 115 1395-79
[7]
Chandra A(2008)National academy of clinical biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers Clin Chem 54 e11-2374
[8]
Pius C(2018)Exosomes in cancer development and clinical applications Cancer Sci 109 2364-303
[9]
Nabeel M(2019)Exosomes: biogenesis, biologic function and clinical potential Cell Biosci 9 19-12
[10]
Nair M(2017)Exosomal DNMT1 mediates cisplatin resistance in ovarian cancer Cell Biochem Funct 35 296-1616